SLRN
ACELYRIN, INC. Common Stock
NASDAQ: SLRN · HEALTHCARE · BIOTECHNOLOGY
$2.27
+0.00% today
Updated 2026-04-30
Market cap
$229.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.69
Dividend yield
—
52W range
$2 – $3
Volume
4.1M
ACELYRIN, INC. Common Stock (SLRN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-51.10%
ROA
-29.80%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $0.00 | $-41.84M | — | — | — |
| 2022 | $0.00 | $-250.46M | — | — | — |
| 2023 | $0.00 | $-381.64M | — | — | — |
| 2024 | $0.00 | $-248.23M | — | — | — |